Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:activeIngredient |
gptkb:naltrexone
|
| gptkbp:administeredBy |
oral tablet
|
| gptkbp:approvalYear |
1994
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:N07BB04
|
| gptkbp:contraindication |
liver failure
acute hepatitis |
| https://www.w3.org/2000/01/rdf-schema#label |
ReVia
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness fatigue headache |
| gptkbp:usedFor |
alcohol dependence
opioid dependence |
| gptkbp:bfsParent |
gptkb:Naltrexone
|
| gptkbp:bfsLayer |
6
|